- Home
- JXG vs CHEK Comparison
JXG vs CHEK Comparison
Compare JXG & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JXG
- CHEK
- Stock Information
- Founded
- JXG N/A
- CHEK 2004
- Country
- JXG China
- CHEK Israel
- Employees
- JXG N/A
- CHEK N/A
- Industry
- JXG
- CHEK Medical Electronics
- Sector
- JXG
- CHEK Health Care
- Exchange
- JXG Nasdaq
- CHEK Nasdaq
- Market Cap
- JXG 5.0M
- CHEK 5.1M
- IPO Year
- JXG N/A
- CHEK 2015
- Fundamental
- Price
- JXG N/A
- CHEK $1.23
- Analyst Decision
- JXG
- CHEK
- Analyst Count
- JXG 0
- CHEK 0
- Target Price
- JXG N/A
- CHEK N/A
- AVG Volume (30 Days)
- JXG 434.6K
- CHEK 15.5K
- Earning Date
- JXG 05-12-2025
- CHEK 02-14-2025
- Dividend Yield
- JXG N/A
- CHEK N/A
- EPS Growth
- JXG N/A
- CHEK N/A
- EPS
- JXG 0.48
- CHEK N/A
- Revenue
- JXG $31,840,588.00
- CHEK N/A
- Revenue This Year
- JXG N/A
- CHEK N/A
- Revenue Next Year
- JXG N/A
- CHEK N/A
- P/E Ratio
- JXG $1.71
- CHEK N/A
- Revenue Growth
- JXG N/A
- CHEK N/A
- 52 Week Low
- JXG $0.76
- CHEK $0.56
- 52 Week High
- JXG $0.84
- CHEK $3.45
- Technical
- Relative Strength Index (RSI)
- JXG N/A
- CHEK 26.97
- Support Level
- JXG N/A
- CHEK $0.56
- Resistance Level
- JXG N/A
- CHEK $0.63
- Average True Range (ATR)
- JXG 0.00
- CHEK 0.04
- MACD
- JXG 0.00
- CHEK 0.00
- Stochastic Oscillator
- JXG 0.00
- CHEK 18.87
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.